James F. Oliviero III, the CEO, President, and Director of Checkpoint Therapeutics , Inc. (NASDAQ:CKPT), recently sold shares ...

William Garrett Gray, the Chief Financial Officer of Checkpoint Therapeutics , Inc. (NASDAQ:CKPT), recently sold 74,110 shares of the company’s common stock. The shares were sold at a weighted average ...

A look at the shareholders of Checkpoint Therapeutics, Inc. ( NASDAQ:CKPT) can tell us which group is most powerful. With 56% stake, individual investors possess the maximum shares in the company. In ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on QuidelOrtho (QDEL – Research Report) and Palatin ...

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.

Boston-based Bicara launched in 2021 and is a subsidiary of Indian pharma company Biocon, which provided its seed funding. Bicara is also studying ficerafusp alfa, its lead candidate, in anal cancer ...